An FDA deadline instructing compounding pharmacies and telehealth companies to stop selling compounded versions of Ozempic and Zepbound has not stopped the copycat market, The Wall Street Journal reported May 18. After the FDA declared the yearslong shortages of Novo…
The Latest
Jason Carter has been appointed president and COO of Duke Regional Hospital in Durham, N.C., effective immediately, after serving in the roles on an interim basis for the past six months. Mr. Carter brings two decades of healthcare leadership experience…
John LaPorta has been named CFO of Summit (N.J.) Oaks Hospital, according to a May 17 LinkedIn post. Prior to his new role, Mr. LaPorta served as manager of revenue management for Penn Medicine Princeton (N.J.) Health, according to his…
Linda Walker has been appointed CEO of Llano (Texas) Regional Hospital, effective May 19. Llano Regional established independent governance on April 1, according to a May 19 hospital news release. In her new role, Ms. Walker will oversee operations and…
Michele Morrison, RN, has been named president and chief hospital executive of JFK University Medical Center in Edison, N.J., after serving in those roles on an interim basis. Ms. Morrison has been part of Edison-based Hackensack Meridian Health for nearly…
As reports of violence at hospitals and medical centers continue to reverberate across the U.S., healthcare leaders are focusing on the safety of employees, patients and visitors. To this end, hospitals and health systems are more tightly integrating violence prevention…
Josh Kooistra, DO, was appointed president of Corewell Health in West Michigan. Dr. Kooistra, an associate dean for the College of Human Medicine at East Lansing-based Michigan State University, has served in the role on an interim basis since December,…
Moody’s has downgraded Children’s Hospital Los Angeles’ rating to “Baa3” from “Baa2.” The hospital has recorded three consecutive years of weak financial performance and has been challenged to rebuild liquidity, Moody’s said in a May 15 report. A contributing factor…
The FDA has approved Novavax’s COVID-19 vaccine, Nuvavoxid, for use in adults 65 and older and in individuals ages 12-64 who have at least one underlying health condition. The approval is based on phase 3 clinical trial data that showed…
The FDA cleared the first blood test intended to help in diagnosing Alzheimer’s, marking a significant step in making diagnosis more accessible and less invasive. The test is designed for adults 55 and older who are showing signs or symptoms…